Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220006397 220002471 0 0 Disease modification (D) 2015-12-11 2015-12-11 Nilotinib N N 220030218 NILOTINIB
220006398 220002471 null null Disease modification (D) 2016-08-12 2016-08-12 Nilotinib N N 220030218 NILOTINIB
220006399 220002472 0 65 Curative (C) 2017-08-04 2017-08-11 Nilotinib N N 220030228 NILOTINIB
220006400 220002472 1.96 65.8 Curative (C) null 2016-11-18 AML 19 TRIAL N N 220030228 AML19 TRIAL
220006401 220002472 1.7 0 Curative (C) 2017-01-17 2017-01-18 Nilotinib N N 220030228 NILOTINIB
220006402 220002472 null null Curative (C) 2016-05-04 2016-05-05 AML MyeChild 01 A Mitozantrone/Cytarabine 1 N 220030228 NOT MATCHED
220006403 220002473 null null Disease modification (D) 2016-02-06 2016-02-17 Nilotinib N N 220030238 NILOTINIB
220006404 220002473 1.55 63 null 2016-03-04 2016-03-04 FLAG + Idarubicin null null 220030238 FLAG + IDARUBICIN
220006405 220002474 null 52.1 Curative (C) 2015-02-02 2015-02-02 APML Consolidation II ATRA,Idarubicin N N 220030242 NOT MATCHED
220006406 220002474 1.6 null Curative (C) 2017-03-25 2017-03-27 FBC Conditionining N N 220030242 NOT MATCHED
220006407 220002474 null null Not known (9) 2013-03-19 2013-03-19 AML Interim Guidelines N N 220030242 NOT MATCHED
220006408 220002474 null null Disease modification (D) 2015-03-21 2015-08-27 Nilotinib N N 220030242 NILOTINIB
220006409 220002474 1.58 86.1 Curative (C) null 2013-01-25 AML 19 TRIAL Y N 220030242 AML19 TRIAL
220006410 220002475 0 null Not known (9) 2014-11-19 2014-11-19 Nilotinib 2 N 220030250 NILOTINIB
220006411 220002475 1.62 73 Curative (C) 2016-07-12 2016-07-15 FLAG + Idarubicin null N 220030250 FLAG + IDARUBICIN
220006412 220002475 1.79 66.25 Curative (C) 2014-04-14 2014-04-15 AML 19 TRIAL Y N 220030250 AML19 TRIAL
220006413 220002475 null 38.1 Disease modification (D) 2016-07-12 2016-07-12 AML Interim Guidelines 2 N 220030250 NOT MATCHED
220006414 220002475 null 48 Curative (C) 2013-07-31 2014-01-13 NB HRNBL-1 COJEC Ind COURSE A Y N 220030250 NOT MATCHED
220006415 220002475 1.7 85 Curative (C) 2013-04-24 2013-04-24 FLAG + Idarubicin null N 220030250 FLAG + IDARUBICIN
220006416 220002475 1.7 null Curative (C) 2017-01-21 2017-05-01 null N N 220030250 NOT MATCHED
220006417 220022003 0 0 Curative (C) 2017-11-20 2017-11-21 Nilotinib N N 220030271 NILOTINIB
220006418 220002476 0 89.7 Disease modification (D) 2013-07-31 2013-07-31 Nilotinib N N 220030272 NILOTINIB
220006419 220002476 1.61 100 Curative (C) 2014-05-18 2014-05-18 AML 19 TRIAL 1 N 220030272 AML19 TRIAL
220006420 220002476 1.8 54.6 Curative (C) 2016-04-18 2016-04-19 AML 19 TRIAL Y N 220030272 AML19 TRIAL
220006421 220002477 null 53.5 Palliative (P) 2017-10-13 2017-11-13 Nilotinib N N 220030276 NILOTINIB
220006422 220011412 null 55.3 Disease modification (D) 2014-01-07 2014-01-07 Nilotinib N N 220030281 NILOTINIB
220006423 220002478 1.76 86.7 Curative (C) 2013-03-26 2013-03-26 FLAG + Idarubicin 99 N 220030283 FLAG + IDARUBICIN
220006424 220011413 1.68 81.7 Curative (C) 2015-07-09 2015-07-09 AML 19 TRIAL N N 220030284 AML19 TRIAL
220006425 220011413 0 53.5 null 2016-02-09 2016-02-15 Nilotinib N N 220030284 NILOTINIB
220006426 220011413 null 0 Curative (C) 2013-06-18 2013-06-27 null 2 N 220030284 NOT MATCHED
220006427 220011413 1.63 0 Curative (C) 2014-06-08 2014-06-11 null N null 220030284 NOT MATCHED
220006428 220011413 1.62 76.7 Curative (C) 2016-02-01 2016-02-08 AML 19 TRIAL null N 220030284 AML19 TRIAL
220006429 220021732 1.7 53.8 Curative (C) 2014-07-02 2014-07-04 AML 19 TRIAL 02 N 220030294 AML19 TRIAL
220006430 220022004 null 0 Disease modification (D) 2017-12-22 2017-12-23 Nilotinib N N 220030295 NILOTINIB
220006431 220002479 null 70 Curative (C) 2014-08-20 2014-08-20 AML Relapsed High Dose Cytarabine null null 220030297 NOT MATCHED
220006432 220002479 0 82.7 Palliative (P) 2016-05-11 2016-05-11 Nilotinib 02 N 220030297 NILOTINIB
220006433 220002480 1.64 72.8 Curative (C) 2016-09-02 2016-09-03 AML 19 TRIAL 1 N 220030299 AML19 TRIAL
220006434 220002481 0 0 Curative (C) 2014-04-30 2014-04-30 AML Downs AIE N N 220030302 NOT MATCHED
220006435 220002481 1.69 68.8 Curative (C) null 2015-01-15 AML 19 TRIAL 1 N 220030302 AML19 TRIAL
220006436 220002481 1.59 115.9 Curative (C) 2016-11-04 2016-11-04 AML 19 TRIAL Y N 220030302 AML19 TRIAL
220006437 220002481 1.85 104.2 Curative (C) 2016-06-30 2016-07-02 AML 19 TRIAL Y N 220030302 AML19 TRIAL
220006438 220002482 1.52 75.3 Curative (C) 2016-11-10 2016-11-13 AML 19 TRIAL Y N 220030310 AML19 TRIAL
220006439 220002482 null 81 Curative (C) 2016-09-23 2016-09-29 AML 19 TRIAL N N 220030310 AML19 TRIAL
220006442 220002484 1.78 79.2 Curative (C) 2014-06-02 2014-06-02 AML 19 TRIAL Y N 220030315 AML19 TRIAL
220006443 220002484 1.68 78.5 Curative (C) 2014-11-15 2014-11-15 AML 19 TRIAL Y N 220030315 AML19 TRIAL
220006444 220002485 0 0 Disease modification (D) 2016-03-13 2017-04-05 Nilotinib 2 N 220030318 NILOTINIB
220006445 220002485 1.66 97.2 Curative (C) 2014-12-19 2014-12-21 AML 19 TRIAL 1 N 220030318 AML19 TRIAL
220006446 220016143 null 108 Curative (C) 2017-03-24 2017-03-25 AML 19 TRIAL Y N 220030320 AML19 TRIAL
220006447 220016143 0 null Curative (C) 2017-05-31 2017-05-31 Nilotinib 2 N 220030320 NILOTINIB
220006448 220016143 1.65 91.4 Curative (C) 2013-12-12 2013-12-12 AML 19 TRIAL N N 220030320 AML19 TRIAL